Acta Scientific Pharmacology

Short Communication Volume 4 Issue 1

Prudent Use of NSAIDs in Patients with COVID-19, Dengue, and Chikungunya

Abdul Kader Mohiuddin*

Alumni, Faculty of Pharmacy, Dhaka University, Bangladesh

*Corresponding Author: Abdul Kader Mohiuddin, Alumni, Faculty of Pharmacy, Dhaka University, Bangladesh.

Received: December 01, 2022 Published: December 23, 2022

Abstract

NSAIDs are most common pharmacological options for pain management, although their use is questionable in many viral diseases like COVID-19, Dengue, and Chikungunya. Newer studies suggest to limit their use in such cases and also reinforces more careful considerations in patients with liver and kidney injuries or concurrent administration with other drugs/nutraceuticals such as antioxidants or SSRIs.

Keywords: Pain Management; Cautions with SSRIs; Hypertensive Patients with Viral Fever, Misuse of NSAIDs, NSAIDs in Kidney or Liver-compromised Patients

References

  1. Lucas GNC., et al. “Pathophysiological aspects of nephropathy caused by non-steroidal anti-inflammatory drugs”. Brazilian Journal of Nephrology 1 (2019): 124-130.
  2. Davis Abigail and John Robson. “The Dangers of Nsaids: Look Both Ways”. British Journal of General Practice 645 (2016): 172-173.
  3. Mohiuddin Abdul Kader. “Medication Adherence: Fact or Fictions?” Open Journal of Pharmaceutical Science and Research 4 (2022): 6-10.
  4. Esposito Pasquale., et al. “Changes of Acute Kidney Injury Epidemiology during the COVID-19 Pandemic: A Retrospective Cohort Study”. Journal of Clinical Medicine12 (2022): 3349.
  5. Gabrielli M., et al. “Liver Injury in Patients Hospitalized for COVID-19: Possible Role of Therapy”. Vaccines 10 (2022): 192.
  6. Peng Mei., et al. “Role of Hypertension on the Severity of COVID-19: A Review”. Journal of Cardiovascular Pharmacology5 (2021): e648-e655.
  7. Sharp TM., et al. “Clinical Characteristics, Histopathology, and Tissue Immunolocalization of Chikungunya Virus Antigen in Fatal Cases”. Clinical Infectious Diseases 2 (2021): e345-e354.
  8. Stöllberger C and Finsterer J. “Nonsteroidal anti-inflammatory drugs in patients with cardio- or cerebrovascular disorders”. Zeitschrift für Kardiologie9 (2003): 721-729.
  9. Alam SM., et al. “Selective serotonin reuptake inhibitors increase risk of upper gastrointestinal bleeding when used with NSAIDs: a systemic review and meta-analysis”. Scientific Report1 (2022): 14452.
  10. Mohiuddin A K. “Chapter 29. Non-Drug Pain Management”. The Role of the Pharmacist in Patient Care: Achieving High Quality, Cost-Effective and Accessible Healthcare Through a Team-Based, Patient-Centered Approach, Universal-Publishers, (2020): 570-519.

Citation

Citation: Abdul Kader Mohiuddin. “Prudent Use of NSAIDs in Patients with COVID-19, Dengue, and Chikungunya". Acta Scientific Pharmacology 4.1 (2023): 18-20.

Copyright

Copyright: © 2022 Abdul Kader Mohiuddin. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate36%
Acceptance to publication20-30 days

Indexed In


News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is May 30, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US